Novel insights into beta-blocker therapy for long QT syndromes
- James P. Daubert(corresponding author),
- Augustus O. Grant,
- Kent R. Nilsson
- Duke University
Scholary Output:
Contribution to journal
Editorial
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Editorial
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 2100-2102 (3 pages)Journal (Volume, Issue Number)
Journal of the American College of Cardiology (Volume 60, Issue 20)Publication milestones
- Published - 11/13/2012
Publication status
Published - 11/13/2012
ISSN
0735-1097Publication IDs
- Scopus: 84868565078
- PubMed: 23083777
Publication metrics
Metrics
SciVal
citations
2
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
1.04
SciVal
Author count
3
SciVal
Paper percentile
40
PlumX, opens in new tab
Citation count
5
Captures
28
Funding Details
Dr. Daubert has received honoraria and research grants from Medtronic , Biosense Webster , Boston Scientific , St. Jude Medical , Sorin Medical , Biotronik , Premier, Inc. , and Gilead ; and has equity in Johnson and Johnson. Dr. Grant is a consultant to Sanofi Aventis and Unilever. Dr. Nilsson has received research grants from Medtronic and honorari from Janssen Pharmaceutical.
FundersFunding numbers
Boston Scientific , St. Jude Medical
-Sorin Medical
-Medtronic
-Gilead Sciences
-Biosense Webster
-Janssen Pharmaceuticals
-Biotronik
-